McKesson | MCK - Ebitda

Stock Price
759.36
Daily Change
12.13 1.62%
Monthly
-12.45%
Yearly
4.86%
Q2 Forecast
720.85

McKesson reported $1.88B in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Acadia Healthcare USD 144.22M 44.37M Mar/2026
Align Technology USD 260.87M 77.03M Dec/2025
Cardinal Health USD 1.09B 109M Mar/2026
Centene USD 2.56B 3.47B Mar/2026
Charles River Laboratories USD 229.8M 28.26M Mar/2026
Cigna USD 2.86B 56M Mar/2025
Community Health Systems USD 395M 19M Dec/2025
Computer Programs Systems USD 19.2M 10.52M Dec/2025
CVS Health USD 5.83B 2.08B Mar/2026
DaVita Healthcare Partners USD 659.83M 112.87M Mar/2026
Dentsply International USD 129M 6M Mar/2026
Elevance Health USD 4.21B 2.02B Mar/2026
Encompass Health USD 348.8M 13.2M Mar/2026
HCA USD 3.8B 312M Mar/2026
Henry Schein USD 289M 2M Mar/2026
Humana USD 2.06B 2.35B Mar/2026
IQVIA Holdings USD 932M 114M Mar/2026
J&J USD 7.19B 2.32B Dec/2025
Laboratory Of America USD 605.6M 17.5M Mar/2026
McKesson USD 1.88B 206M Dec/2025
Molina Healthcare USD 267M 385M Mar/2026
Owens Minor USD 90.02M 2.15M Dec/2025
Quest Diagnostics USD 557M 20M Mar/2026
Stryker USD 1.57B 618M Mar/2026
Tenet Healthcare USD 1.16B 21M Mar/2026
UnitedHealth USD 9.99B 8.5B Mar/2026
Universal Health Services USD 678.67M 8.07M Dec/2025
Veradigm USD 38.81M 29.61M Sep/2022